These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7794791)

  • 1. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
    Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
    Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW
    Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1994 Mar; 5(3):287-94. PubMed ID: 8018561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A; Espanel X; Brun G
    Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
    Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q; Li J; Cenkci B; Kretzner L
    Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
    Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
    J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
    Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
    Batsché E; Lipp M; Cremisi C
    Oncogene; 1994 Aug; 9(8):2235-43. PubMed ID: 8036009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site.
    Ouellette MM; Chen J; Wright WE; Shay JW
    Oncogene; 1992 Jun; 7(6):1075-81. PubMed ID: 1534398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins.
    Majello B; De Luca P; Suske G; Lania L
    Oncogene; 1995 May; 10(9):1841-8. PubMed ID: 7753559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions.
    Lind EF; Wayne J; Wang QZ; Staeva T; Stolzer A; Petrie HT
    J Immunol; 1999 May; 162(9):5374-9. PubMed ID: 10228014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells.
    Sala A; Nicolaides NC; Engelhard A; Bellon T; Lawe DC; Arnold A; Graña X; Giordano A; Calabretta B
    Cancer Res; 1994 Mar; 54(6):1402-6. PubMed ID: 8137237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG; Moses HL
    J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.